Physician profile
Felice L Gersh
NPI 1598850919
$19,272.16
in general payments reported to CMS, 2019-2025
12 companies · $2,126 in 2025
The $2,126 reported for 2025 was more than what 90% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $144 · 2021: $33.41 · 2022: $1,701 · 2023: $5,741 · 2024: $9,370 · 2025: $2,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,650 · Food and Beverage: $1,163 · Travel and Lodging: $182 · Gift: $34.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,207.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,650.00 |
| Food and Beverage | $1,162.51 |
| Travel and Lodging | $182.38 |
| Gift | $34.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $12,483.32 | 2019-2024 | Tirosint, Tirosint, Licart |
| Ascend Therapeutics US, LLC | $4,217.59 | 2022-2024 | |
| Novo Nordisk INC | $1,907.50 | 2025 | |
| Exact Sciences Corporation | $223.43 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Mayne Pharma Commercial LLC | $127.07 | 2025 | |
| Minerva Surgical, INC | $105.54 | 2019 | |
| Acella Pharmaceuticals, LLC | $88.13 | 2022-2025 | NP Thyroid 60 |
| Abbvie INC. | $38.06 | 2019-2022 | |
| Hologic Sales and Service, LLC | $29.72 | 2023 | Aptima |
| Exeltis, USA INC. | $23.58 | 2023 | Slynd |
| Astellas Pharma US INC | $14.76 | 2024 | Veozah |
| Coopersurgical, INC. | $13.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felice Gersh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.